GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotechnology Assets SA (XMAD:BST) » Definitions » 5-Year Yield-on-Cost %

Biotechnology Assets (XMAD:BST) 5-Year Yield-on-Cost % : 0.00 (As of May. 25, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Biotechnology Assets 5-Year Yield-on-Cost %?

Biotechnology Assets's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Biotechnology Assets's 5-Year Yield-on-Cost % or its related term are showing as below:



XMAD:BST's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.8
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Biotechnology Assets's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Biotechnology Assets's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotechnology Assets's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotechnology Assets's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Biotechnology Assets's 5-Year Yield-on-Cost % falls into.



Biotechnology Assets 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Biotechnology Assets is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Biotechnology Assets  (XMAD:BST) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Biotechnology Assets 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Biotechnology Assets's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotechnology Assets (XMAD:BST) Business Description

Traded in Other Exchanges
N/A
Address
Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.